Susanne Kaae , Sara Sommer Holst , Johanne Mølby Hansen , Charlotte Vermehren
{"title":"新程序理论在药剂师主导的病人为中心的药物审查在全科实践-定性试点研究。","authors":"Susanne Kaae , Sara Sommer Holst , Johanne Mølby Hansen , Charlotte Vermehren","doi":"10.1016/j.sapharm.2025.07.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Pharmacists are increasingly engaged in general practice to contribute to rational prescribing and to reduce the workloads. To further improve patients' outcomes, a new <em>patient-centered</em> medication review (MR) model in primary care for polypharmacy patients was developed. This model involves patients in an initial ‘problem detection meeting’ with the pharmacist and in a meeting with the pharmacist and the General Practitioner (GP) to discuss MR findings.</div></div><div><h3>Objectives</h3><div>To pilot test the new MR model to supplement existing program theory.</div></div><div><h3>Methods</h3><div>Qualitative descriptive nonparticipatory observations of the MR model were carried out in two general practices in Denmark to identify Context elements and determine how the Intervention was enacted. Semistructured interviews with GPs, patients and the pharmacist were conducted to establish Outcomes. Through principles of realist evaluation, Mechanisms, i.e., links connecting Context, Intervention and Outcomes, were inferred.</div></div><div><h3>Results</h3><div>The new model led to satisfaction among patients and GPs. Three central mechanisms were: 1) alignment between the pharmacist and the GP in their understanding of MR work; 2) investment in relational work; and 3) flexibility, allowing the model to fulfill the needs of GPs despite differences in experiences with polypharmacy, working styles, and knowledge of enrolled patients.</div></div><div><h3>Conclusion</h3><div>The new model illustrates how pharmacists can support GPs. New program theory regards the importance of compatible perspectives between pharmacists and GPs on appropriate polypharmacy work, i.e., ‘shared mental models’, the ways GPs can develop their mental models when interacting with pharmacists, and the usefulness of relational work when the models clash.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"21 12","pages":"Pages 1070-1078"},"PeriodicalIF":2.8000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"New program theory in pharmacist-led patient-centered medication review in general practice: A qualitative pilot study\",\"authors\":\"Susanne Kaae , Sara Sommer Holst , Johanne Mølby Hansen , Charlotte Vermehren\",\"doi\":\"10.1016/j.sapharm.2025.07.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Pharmacists are increasingly engaged in general practice to contribute to rational prescribing and to reduce the workloads. To further improve patients' outcomes, a new <em>patient-centered</em> medication review (MR) model in primary care for polypharmacy patients was developed. This model involves patients in an initial ‘problem detection meeting’ with the pharmacist and in a meeting with the pharmacist and the General Practitioner (GP) to discuss MR findings.</div></div><div><h3>Objectives</h3><div>To pilot test the new MR model to supplement existing program theory.</div></div><div><h3>Methods</h3><div>Qualitative descriptive nonparticipatory observations of the MR model were carried out in two general practices in Denmark to identify Context elements and determine how the Intervention was enacted. Semistructured interviews with GPs, patients and the pharmacist were conducted to establish Outcomes. Through principles of realist evaluation, Mechanisms, i.e., links connecting Context, Intervention and Outcomes, were inferred.</div></div><div><h3>Results</h3><div>The new model led to satisfaction among patients and GPs. Three central mechanisms were: 1) alignment between the pharmacist and the GP in their understanding of MR work; 2) investment in relational work; and 3) flexibility, allowing the model to fulfill the needs of GPs despite differences in experiences with polypharmacy, working styles, and knowledge of enrolled patients.</div></div><div><h3>Conclusion</h3><div>The new model illustrates how pharmacists can support GPs. New program theory regards the importance of compatible perspectives between pharmacists and GPs on appropriate polypharmacy work, i.e., ‘shared mental models’, the ways GPs can develop their mental models when interacting with pharmacists, and the usefulness of relational work when the models clash.</div></div>\",\"PeriodicalId\":48126,\"journal\":{\"name\":\"Research in Social & Administrative Pharmacy\",\"volume\":\"21 12\",\"pages\":\"Pages 1070-1078\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Research in Social & Administrative Pharmacy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1551741125003808\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Social & Administrative Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551741125003808","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
New program theory in pharmacist-led patient-centered medication review in general practice: A qualitative pilot study
Background
Pharmacists are increasingly engaged in general practice to contribute to rational prescribing and to reduce the workloads. To further improve patients' outcomes, a new patient-centered medication review (MR) model in primary care for polypharmacy patients was developed. This model involves patients in an initial ‘problem detection meeting’ with the pharmacist and in a meeting with the pharmacist and the General Practitioner (GP) to discuss MR findings.
Objectives
To pilot test the new MR model to supplement existing program theory.
Methods
Qualitative descriptive nonparticipatory observations of the MR model were carried out in two general practices in Denmark to identify Context elements and determine how the Intervention was enacted. Semistructured interviews with GPs, patients and the pharmacist were conducted to establish Outcomes. Through principles of realist evaluation, Mechanisms, i.e., links connecting Context, Intervention and Outcomes, were inferred.
Results
The new model led to satisfaction among patients and GPs. Three central mechanisms were: 1) alignment between the pharmacist and the GP in their understanding of MR work; 2) investment in relational work; and 3) flexibility, allowing the model to fulfill the needs of GPs despite differences in experiences with polypharmacy, working styles, and knowledge of enrolled patients.
Conclusion
The new model illustrates how pharmacists can support GPs. New program theory regards the importance of compatible perspectives between pharmacists and GPs on appropriate polypharmacy work, i.e., ‘shared mental models’, the ways GPs can develop their mental models when interacting with pharmacists, and the usefulness of relational work when the models clash.
期刊介绍:
Research in Social and Administrative Pharmacy (RSAP) is a quarterly publication featuring original scientific reports and comprehensive review articles in the social and administrative pharmaceutical sciences. Topics of interest include outcomes evaluation of products, programs, or services; pharmacoepidemiology; medication adherence; direct-to-consumer advertising of prescription medications; disease state management; health systems reform; drug marketing; medication distribution systems such as e-prescribing; web-based pharmaceutical/medical services; drug commerce and re-importation; and health professions workforce issues.